SCHEMBL6498751

SCHEMBL6498751

COC(=O)C(C)NC(=O)C1CCN(C(=O)/C=C/c2ccc(N(C)C)c(C(F)(F)F)c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 4/20 0.47
NPC1 O15118 8/20 0.43
RAB9A P51151 8/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
ITGAL P20701 3/20 0.41
ITGB2 P05107 2/20 0.41
ICAM1 P05362 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.40
POLB P06746 1/20 0.40
KDM4E B2RXH2 1/20 0.39
APOBEC3A P31941 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
BCHE P06276 2/20 0.38
MAOA P21397 2/20 0.38
ACHE P22303 2/20 0.38
MAOB P27338 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6498757 1.00 CAPN1 (0.47) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6498135 0.91 CAPN1 (0.47) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6498130 0.91 CAPN1 (0.47) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL8298766 0.91 CAPN1 (0.47) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6498794 0.87 CAPN1 (0.49) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6498797 0.87 CAPN1 (0.49) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6503200 0.84 ITGB2 (0.49) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6503201 0.84 ITGB2 (0.49) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL8296931 0.83 SMN1; SMN2 (0.47) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6495765 0.79 CAPN1 (0.47) CAPN1NPC1RAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed